Introduction {#sec1-1}
============

Alarming epidemiological data have been reported for many tumour histotypes, particularly for head and neck squamous cell carcinomas (HNSCC), including oral (OSCC). Indeed, an increase in diagnosis from the present \~300,000 cases worldwide to \~500,000 is expected within 2035 (+65%). More worryingly, the \~115,000 OSCC currently diagnosed in elderly patients (≥ 65 years old) are expected to double (about +104%) in the next 20 years, while those in younger will "only" increase by about 40% ^[@ref1]^.

Current guidelines for treatment of OSCC require surgery as the preferred approach, whereas they suggest radiotherapy or chemoradiotherapy for advanced-stage cancer in the presence of adverse features ^[@ref2]^. Photodynamic therapy may be otherwise considered as an approach for the management of previously-treated patients or for those who are not suitable for conventional therapies. Therefore, complex reconstructive surgeries have been used more and more frequently in the last two decades to improve the post-treatment quality of life. However, this trend determines an extension of surgical times, as well as a general need to carefully select patients, which is based on the most serious comorbidity to reduce complications and overall costs. In this scenario, elderly patients are not considered to be good candidates to undergo more challenging treatments, e.g. highly invasive resective/reconstructive surgery and complex chemotherapy schedule ^[@ref3]^.

To provide surgeons with a model to choose the most appropriate treatment options, we retrospectively analysed 99 patients aged at least 70, suffering for OSCC, and treated with radical intent with 3 different types of surgery: transoral procedures (TP), open neck resection without reconstruction (OR) and open neck resection with reconstruction (ORR). Major outcomes as well as the incidence of post-treatment complications were evaluated, whereas predictive factors involved in their occurrence were identified.

Materials and methods {#sec1-2}
=====================

Patients and surgery {#sec2-1}
--------------------

After informed consent was obtained, all patients underwent surgery for OSCC at the Policlinico Hospital in Modena or at the Martini - San Luigi Gonzaga Hospitals of Turin between January 1, 2001, and December 31, 2012. Data collection from the medical charts included demographic information such as age and sex, TNM staging, tumour site and subsite, tumour histology, physical status according to the American Society of Anesthesiologists (ASA) ^[@ref4]^, age at the surgical time, type of surgery and neck dissection, type of reconstruction, duration of surgery, duration of hospitalisation (including days in intensive care unit, ICU), comorbidities and perioperative complications. The assessed comorbidities were diabetes mellitus, hypertension, chronic obstructive pulmonary disease (COPD), cardiac diseases (including chronic heart failure, arrhythmia and coronary artery disease), hepatic, metabolic and cerebrovascular diseases.

In the present retrospective study, age at the time of surgery ≥ 70 years ^[@ref5]^, histological diagnosis of OSCC and surgical treatment with curative intent (as single modality or as part of a multimodality approach) were considered as inclusion criteria.

The chart data of 99 patients were retrieved. The choice of the treatment was based on tumour stage and site, as well as comorbidities, but non-considering chronological age as a discriminatory factor. Procedures were classifiable as transoral procedures (TP), meaning mini-microinvasive surgeries as well as the non-surgical photodynamic therapy, in 14 of 99 patients (14.1%), open neck resection without reconstruction (OR) in 59 of 99 patients (59.6%) and open neck resection with reconstruction (ORR) in 26 of 99 patients (26.3%).

Characteristics of the patient cohort are summarised in [Table I](#table001){ref-type="table"}, while stratification according to tumour site and sub-site is reported in [Table II](#table002){ref-type="table"}.

Statistical analysis {#sec2-2}
--------------------

The length of time from the date of diagnosis to the date of death (overall survival, OS) or to the date of death for disease (disease-specific survival, DSS) was estimated using Kaplan-Meier curves. At the end of the study, the dates of last consultation for patients still alive were used for type-I censoring. Log-rank and Gehan-Breslow-Wilcoxon tests (for early events) were used to compare Kaplan-Meier estimates between groups (number of comorbidities, tumour site, type of surgery and postoperative complications). The CHAID (Chi-square Automatic Interaction Detection) method ^[@ref8]^ was used to detect the optimal subdivision to maximise the differences in response within the different variables.

Univariate regression with colinearity analysis was used to evaluate independent risk factors (e.g. age at the surgery ≥ 80 ^[@ref9]^, gender, presence of comorbidities, tumour stage, type of surgery and duration of surgery) for development of perioperative and postoperative complications (within 30 days). Those significantly associated were included in a multivariable logistic regression model.

Kaplan-Meier curves, log-rank and Gehan-Breslow-Wilcoxon tests were performed with Graphpad Prism version 6.0e (GraphPad Software, San Diego, CA, USA), whereas CHAID analysis, univariate regression with colinearity analysis and multivariate logistic regression were performed with IBM^®^ SPSS^®^ Statistics version 23 (IBM Corp., Armonk, NY, USA). All analyses were considered statistically significant at p \< 0.05.

Results {#sec1-3}
=======

Patient comorbidities {#sec2-3}
---------------------

Concomitant diseases were present in 69 of 99 (69.7%) elderly patients, of whom 32 (32.3%) were affected by multiple (≥ 2) comorbidities. The most frequent were hypertension (50.5%), cardiovascular disease (25.2%), diabetes mellitus (19.2%) and chronic obstructive pulmonary disease (COPD) (12.1%). The severity of each comorbidity was scored and recorded according to the American Society of Anesthesiologists (ASA) physical status classification system ^[@ref4][@ref10]^ ([Table III](#table003){ref-type="table"}).

Surgery and postoperative morbidity {#sec2-4}
-----------------------------------

The mean surgical time was 3.4 ± 2.3 h, ranging from 0.5 h to 10.5 h in patients aged 70-79 years and from 0.5 h to 6.5 h in those ≥ 80 years (p = 0.156).

Amongst treated patients, 31 (14 OR and 17 ORR) were postoperatively transferred to the intensive care unit (ICU) where they resided for an average time between 1.6 days (70-79 years old) and 1.1 days (age ≥ 80 years; p = 0.675). Transfer to the ICU was decided by the anesthesiologist and was based on duration of surgery, pre-operative ASA score and complications occurred during surgery. Generally, the mean length of hospitalisation was 21.0 days in 70-79 patients and 18.7 in those aged ≥ 80 years (p = 0.537). Patients were discharged when completely cured and autonomous in major activities (swallowing, breathing or cannula management).

Perioperative or postoperative complications affected 30 of 99 patients (30.3%) of whom 21 of 70 (30.0%) in the age range 70-79 and 9 of 29 (31.0%) in ≥ 80 years (p = 0.890).

Furthermore, stratifying patients for the type of surgery, no differences between groups were observed, although open techniques followed by reconstruction displayed a significantly higher incidence of complications than with other techniques in patients 70-79 years old (p \< 0.05, [Fig. 1](#fig001){ref-type="fig"}).

In the 70-79 year group, 4 patients suffered systemic complications, 9 had local complications (mainly bleedings, fistulas and wound infections) and 5 developed both systemic and local complications. One patient suffered of multiple systemic complications, whereas 1 patient had 2 local complications. Two patients (9.5%) died postoperatively. In the elderly aged ≥ 80, 4 patients developed a systemic complication, 1 patient had 2 systemic complications, whereas 4 patients suffered of local complication. One patient (11.1%) died postoperatively ([Table IV](#table004){ref-type="table"}). Finally, 27 of 99 patients (27.3%) underwent a second surgical procedure, whereas 9 of 99 patients (9.1%) underwent a third salvage surgery.

Correlation of age, comorbidities, tumour site, type of surgery and complications with patient survival {#sec2-5}
-------------------------------------------------------------------------------------------------------

Patients were followed for a mean period of 2.52 years (range 6 days -- 9.3 years). At the last follow-up, 40 of 99 patients (40.4%) were alive without disease, 26 died with disease (26.3%) and 24 died for other reasons than head and neck cancer (24.2%), whereas 8 were alive with disease (8.1%). The remaining patient was lost to follow-up (1.0%).

At 5 years, overall survival (OS, 41.1%) was not significantly affected by patient age at the surgery. In fact, OS was 49.9% in those 70-79 years old and 18.4% in those aged ≥ 80 years (p = 0.176; for early events p = 0.433), with 50% mortality at 3.6 and 1.7 years, respectively ([Fig. 2A](#fig002){ref-type="fig"}). Likewise, 5-year disease-specific survival (DSS, 66.1%) was 64.4% in 70-79 year old patients and 71.6% in the older ones ([Fig. 2B](#fig002){ref-type="fig"}; p = 0.677).

Furthermore, by stratifying chart data, we found that the presence of ≥ 2 comorbidities at diagnosis significantly worsened life expectancy of patients (p \< 0.05). In these cases, OS was 23.9% (50% mortality at 1.5 years), whereas it was 53.4% and 48.2% (50% mortality at 3.9 years), respectively, in patients without or with 1 comorbidity ([Fig. 3a](#fig003){ref-type="fig"}). Otherwise, the anatomical localisation of the pathology had a marginal role (p = 0.510, [Fig. 3b](#fig003){ref-type="fig"}): patients with tumours in the oral cavity had 45.5% OS (50% mortality at 3.6 years), whereas those in which the pathology involved the oropharynx had 35.9% (50% mortality at 2.4 years).

Regarding treatment, OS was affected by the presence of post-operative complications, although the choice of surgical technique did not play a direct role. In fact, 5-year OS of patients who experienced perioperative and postoperative complications was 31.2% (50% mortality at 1.4 years), which is significantly lower (p \< 0.05; for early events p \< 0.01) compared to 46.1% (50% mortality at 4.5 years) of the other patients ([Fig. 3c](#fig003){ref-type="fig"}). Otherwise, patients treated by a more invasive ORR had 5-year OS of 41.0% vs. 42.3% and 52.4% of those treated by OR and TP, respectively (p = 0.754) ([Fig. 3d](#fig003){ref-type="fig"}).

Risk analysis on the development of complications {#sec2-6}
-------------------------------------------------

Even if no variables evaluated displayed colinearity, age ≥ 80 years, gender, previous treatments, ASA physical status classification and duration of surgery did not show statistically significant correlations at univariate regression with the onset of perioperative and postoperative complications. On the contrary, they were correlated with the presence of concomitant diseases, tumour stage and type of surgery.

In fact, patients affected by ≥ 2 comorbidities were prone to develop complications with a risk of 53.1%, which is significantly higher than those with 1 concomitant disease (27.1%, p \< 0.05) or without any comorbidities (10%, p \< 0.001). Similarly, patients who were diagnosed with early stage tumours had a lower risk (13.0% stage I and 16.7% stage II) to incur complications than those with advanced-stage disease (43.8% stage III and 45.7% stage IV, p \< 0.01). Finally, patients undergoing ORR had an higher risk (p \< 0.05) of developing complications (50.0%) compared to those treated by OR (23.7%) or TP (21.4%).

Concomitant diseases, tumour stage and type of surgery were included together with the non-statistically significant age parameter in the following multivariate logistic regression model (p \< 0.001, Likelihood Ratio L test):

![](aoi-2018-05-409-e001){#d35e380}

where: (*a*) = patient aged 70-79; (*b*) = treatment by OR; (*c*) = treatment by ORR; (*d*) = absence of comorbidities; (*e*) = presence of 1 comorbidity; (*f*) = stage-I neoplasm; (*g*) = stage-II neoplasm; (*h*) stage-III neoplasm.

In the regression model ([Table V](#table005){ref-type="table"}), the type of surgery was not statistically significant for the predisposition to develop complications (p = 0.170). Their rate was determined accordingly, stratified for both concomitant diseases and pathology stage, and reported in [Table VI](#table004){ref-type="table"}.

Discussion {#sec1-4}
==========

Worldwide, the progressively aging population makes treatment of elderly patients more frequent than in the past. Nevertheless, the elderly have the tendency to be often considered as a population that should be treated by less invasive/time-consuming procedures. Furthermore, full scientific agreement about not considering age by itself as a risk factor for incidence of surgical complications in the elderly it is still lacking ^[@ref11]^. Consequently, aggressive surgery on older patients has been generally infrequent until now ^[@ref19]^ . However, it has been recently demonstrated for the treatment of laryngeal cancer that the employment of more invasive surgical procedures can also be adequate to treat older patients, albeit with some recommendations ^[@ref20]^.

This finding could also be relevant for oral cancer. In the elderly, indeed, it is almost always (95%) diagnosed as squamous cell carcinoma (OSCC) ^[@ref21][@ref22]^, a tumour histotype characterised by an intrinsic resistance to non-surgical approaches like radiotherapy and chemotherapy (including the newest proton therapy and "target therapy") ^[@ref23]^. The clinical evolution of OSCC has led to a rapid and strong decline in both life quality and expectancy, and includes pain, dysphagia, odynophagia, bleeding, *fetor ex ore*, teeth loss, inability to swallow and tumour externalisation from mouth and facial skin with consequent irreparable, permanent socially disfiguring impairment. The functional, cosmetic and psychological repercussions suffered by OSCC patients frequently result in significant burden for them, their families and society. Generally, their nutritional status is poor and depression is frequent, with important somatic problems that often cause social isolation.

In this context, surgery can be considered the only reliable approach and is, hence, the treatment of choice for all tumour stages ^[@ref2]^. Thus, the exclusion criteria of patients with diagnosis of OSCC from surgery (including more invasive techniques) should be finely defined, avoiding the *a priori* exclusion of older patients to more challenging therapeutic options because wrongly considered as frail ^[@ref10][@ref19]^.

In this retrospective study, we considered a cohort of old (70-79 years) and very old (≥ 80 years) patients ^[@ref9]^ affected by OSCC, in order to understand whether age represents *per se* a contraindication to treatment with open invasive surgery. Both old and very old populations were treated by one of three different approaches (transoral procedures, TP, open neck resection, OR, and open neck resection with reconstruction, ORR), chosen according to tumour stage and site, as well as comorbidities. The distribution of patients to surgical techniques was homogeneous between the two groups. Likewise, no differences were detected among groups after comparison between surgical time, number of ICU and hospitalisation days and incidence of complications. No significant differences were detected in terms of overall survival (OS) at 5 years from surgery, though a poorer 18.4% was detected in ≥ 80 year old patients vs 49.9% of those 70-79 years (p = 0.176). This non-significant difference was likely due to physiological instead of pathological causes, since during the same period disease-specific survival (DSS) was at some extent better (71.6%) in ≥ 80 years than in those 70-79 (64.4%, p = 0.677) years. This finding is further corroborated if we consider younger cohorts. In fact, following 489 patients (median age = 62) affected by oral tumours (40% in advanced stage), Rogers and co-workers ^[@ref26]^ achieved 74% DSS after 5 years from surgical treatment. Furthermore, they reviewed the results from other cohorts in which the 5-year DSS varied from 49% to 84%. Combining the data, we can deduce an overall cohort of 805 patients with a DSS of 73.4% that is completely superimposable (p = 0.871) with our full-cohort DSS (66.1%). By patient stratification, we detected that OS was affected by both comorbidities at diagnosis and post-operative complications. Patients with ≥ 2 comorbidities had 23.9% OS vs. \~50% seen in the others. Similarly, patients who developed complications had 31.2% OS compared to the 46.1% of those who did not (p \< 0.05), although the phenomenon was more evident in the first post-operative years (p \< 0.001). Otherwise, tumour localisation as well as the choice of surgical approach did not have an apparent role in OS, even if we detected a higher incidence of complications (p \< 0.05) in those 70-79 years undergoing a more extended ORR approach. As recently stated by Grammatica and coworkers, reconstruction still remains a complex procedure that affects the development of both local and systemic perioperative complications ^[@ref27]^.

As a confirmatory result, at univariate analysis the factors involved in the development of complications for our patient cohort were the presence of comorbidities, tumour stage and type of surgery employed, rapidly discharging any implication role of age, gender, previous treatments, ASA score and duration of surgical treatment. Nevertheless, at multivariate analysis, the role of each surgical approach became statistically negligible, highlighting a predominant involvement of tumour stage and above all the presence of concomitant diseases. Patients without comorbidities had a small to moderate risk in developing post-operative complications, even facing more advanced pathologies (stage III/IV, 8.5-30.9% risk). At any rate, the risk is already increased for patients facing very early stage tumours, but with ≥ 2 concomitant diseases (I/II, 17.4-50.3% risk).

As final digression, we would conclude that no differences in terms of functional outcomes (oral diet, speech intelligibility, and mouth opening) were detected among old and very old patients. Even if in our cohort much chart data did not report functional outcomes and for this reason results can only be considered as preliminary, they seem to be in accordance with the results of Nao and co-workers ^[@ref28]^, although they compared younger patients (\< 70 vs ≥ 70 years).

Conclusions {#sec1-5}
===========

Up to now, it is widely accepted that elderly OSCC patients could not be treated with the standard of care because of medical prejudices related to advanced age. Nevertheless, our findings support the growing acceptance that chronological age alone should not be a sufficient contraindication for aggressive surgical therapy for OSCC. Instead, the presence of comorbidities at diagnosis might play a pivotal role in the choice of the more appropriate treatment of elderly patients. In multivariate analysis, indeed, comorbidities correlated with the development of postsurgical complications, thus foreclosing access to many treatment options. For these reasons, elderly patients affected by OSCC are undoubtedly delicate surgical candidates and accurate selection based on our results prior to surgery for curative intentions is mandatory.

Sharing and improving our knowledge in elderly patients is helpful for all clinicians due to aging of the population, with the aim to improve the quality of life and overall survival in elderly patients.
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![Overall survival over a 5-year period of patients stratified for: presence of comorbidities at the diagnosis **(A)**, tumour site **(B)**, experience of peri- and/or post-operative complications **(C)**, or employed surgical procedure **(D)**. \* p \< 0.05 (Log-Rank test); \# p \< 0.05, \#\#\# p \< 0.001 (Gehan-Breslow-Wilcoxon test for early events). TP, transoral procedure; OR, open neck resection; ORR, open neck resection with reconstruction.](aoi-2018-05-409-g003){#fig003}

###### 

Characteristics of the 99 elderly patients undergoing head and neck surgery according to age, sex and pathological status.

                                                               No. of patients (%)                                                   
  ------------------------------------------------------------ --------------------- -------- --------- --------- --------- -------- ---------------
  **Age, y**                                                                                                                         
  Mean                                                         77.0 ± 5.6                                                            
  Range                                                        70-93                                                                 
  70-79                                                        70/99 (70.7%)                                                         
  ≥ 80                                                         29/99 (29.3%)                                                         
  **Sex**                                                                                                                            
  Male                                                         60/99 (60.6%)                                                         
  Female                                                       39/99 (39.4%)                                                         
  **Pathological status[\*](#t1fn001){ref-type="table-fn"}**                                                                         
                                                               **N0**                **N1**   **N2a**   **N2b**   **N2c**   **N3**   
  pT1                                                          23                    6        1         4                            34/98 (34.7%)
  pT2                                                          24                    4        1         3         1         1        34/98 (34.7%)
  pT3                                                          3                     4                  4                            11/98 (11.2%)
  pT4                                                          10                    2        1         6                            19/98 (19.4%)

^\*^ *We considered 98 patients because one patient was lacking pTNM.*

###### 

Patient stratification accordingly to the lesion subsites.

                       No. of patients (%)
  -------------------- ---------------------
  **Oral cavity**      74/99 (74.7%)
  Gingiva              9/74 (12.2%)
  Lips                 10/74 (13.5%)
  Tongue               30/74 (40.5%)
  Oral mucosa          16/74 (21.6%)
  Hard palate          2/74 (2.7%)
  Floor of the mouth   7/74 (9.5%)
  **Oropharynx**       25/99 (25.3%)
  Anterior wall        7/25 (28.0%)
  Lateral wall         13/25 (52.0%)
  Superior wall        5/25 (20.0%)

###### 

Distribution of patients according to the American Society of Anesthesiologists (ASA) physical status classification system.

            No. of patients (%)
  --------- ---------------------
  **ASA**   
  1         9/97 (9.3%)
  2         34/97 (35.1%)
  3         43/97 (44.3%)
  4         10/97 (10.3%)
  5         1/97 (1.0%)

###### 

Complications in patients.

  Complications                                                      Number of events (%)   
  --------------------------------------------------- -------------- ---------------------- -------------
  **Local**                                           Fistula        3/21 (14.3%)           1/9 (11.1%)
  Infections                                          5/21 (23.8%)   0/9 (0.0%)             
  Haemorrhage                                         2/21 (9.5%)    1/9 (11.1%)            
  Haematoma                                           0/21 (0.0%)    0/9 (0.0%)             
  Necrosis                                            1/21 (4.8%)    1/9 (11.1%)            
  Dehiscence                                          3/21 (14.3%)   1/9 (11.1%)            
  Wound diastasis                                     0/21 (0.0%)    1/9 (11.1%)            
  Seroma                                              3/21 (14.3%)   0/9 (0.0%)             
  **Systemic**                                        Pneumonia      2/21 (9.5%)            2/9 (22.2%)
  Cardiovascular[\*](#t4fn001){ref-type="table-fn"}   6/21 (28.6%)   1/9 (11.1%)            
  Psychiatric                                         3/21 (14.3%)   1/9 (11.1%)            
  Death                                               2/21 (9.5%)    1/9 (11.1%)            
  Nephropathy                                         0/21 (5.6%)    0/9 (0.0%)             
  Cerebrovascular event                               1/21 (4.8%)    0/9 (0.0%)             
  Hyperglycaemia                                      1/21 (4.8%)    1/9 (11.1%)            
  Sepsis                                              0/21 (0.0%)    0/9 (0.0%)             

\* Cardiovascular complications included acute miocardial infarction, arrhythmia, and cardiac arrest.

###### 

Multivariate regression analyses for the development of post-operative complications.

                                 -2 Log (Λ)   χ^2^     df   P
  ------------------------------ ------------ -------- ---- -------
  Advanced stage                 67.085       9.684    3    0.021
  Comorbidities                  73.974       16.572   2    0.000
  Invasive surgical techniques   60.948       3.547    2    0.170
  Age ≥ 80                       57.942       0.541    1    0.462

Λ, *likelihood ratio;* χ^2^, *chi squared; df, degrees of freedom.*

###### 

Complication risks (%).

                               No. of comorbidities                  
  -------------- ------------- ---------------------- -------------- --------------
                               0                      1              ≥ 2
  Tumour stage   I             1.8 -- 5.4             5.9 -- 11.4    17.4 -- 50.3
  II             2.1 -- 9.4    6.8 -- 25.9            27.9 -- 44.9   
  III            9.6           18.6 -- 52.3           55.0 -- 85.5   
  IV             8.5 -- 30.9   23.8 -- 60.0           62.5 -- 88.9   
